Ottawa Hospital Research Institute

Research News

	Psychedelic use linked to increased risk of schizophrenia, study finds November 13, 2024 - “While there is enormous enthusiasm for psychedelic-assisted therapy as a new mental health treatment, we need to remember how early and limited the data remains for both the benefits and the risks."
	The quest for a good death November 9, 2023 - Dr. Colleen Webber is receiving the Clinical and Applied Health Researcher in Training Award from The Ottawa Hospital for her rigorous and empathetic palliative care research
	Emergency department visits for substance use linked to higher risk of developing schizophrenia September 27, 2023 - People visiting the emergency department (ED) for substance use—particularly cannabis—are at high risk of developing schizophrenia, according to new research.
Show more news stories
	Could a drug that controls appetite also treat schizophrenia and Alzheimer’s? Mouse studies show promise. September 8, 2021 - Two recent studies suggest that the drug trodusquemine has the potential to treat symptoms of both schizophrenia and Alzheimer’s disease. This is because the drug targets an enzyme called PTP1B, which plays a role in both diseases
	A conversation with Dr. Jess Fiedorowicz August 18, 2021 - Dr. Jess Fiedorowicz is shining a light on mental health through his work and research at The Ottawa Hospital. Originally from the U.S., Dr. Fiedorowicz has been at our hospital since 2020 as the Head and Chief of the Department of Mental Health.
	Study in mice reveals possible new target to treat schizophrenia March 10, 2021 - The enzyme PTP1B may be a new target for treating schizophrenia, according to a study published in Neuropsychopharmacology.
	The Ottawa Hospital awarded 18 research grants from the Canadian Institutes of Health Research, worth $10.7 million May 19, 2017 - Eighteen research groups at The Ottawa Hospital, affiliated with the University of Ottawa, have been awarded nearly $11 million in the most recent project grant competition from the Canadian Institutes of Health Research (CIHR). This represents a suc

Researchers

Name	Scientific appointment	Diseases, conditions and populations of interest	Research and clinical approaches
Albert, Paul PhD	Senior Scientist (NS)	Mental health, Vascular cognitive impairment, Anxiety, Depression, Intellectual disabilities, Parkinson's, Schizophrenia, Stroke, Suicide	Basic research, Epigenetics, Exercise, Gene expression, Translational research, Disease models, Epigenetics, Genetics, Imaging, Molecular and cellular biology, Optogenetics, Transgenic/knockout models
Chen, Hsiao-Huei PhD	Senior Scientist (NS)	Aging, Autism, Dementia, Depression, Heart disease, Maternal and fetal health, Mental health, Tourette's, Alzheimer's, Alzheimer's, Anxiety, Diabetes, Obesity, Schizophrenia, Stroke, Vascular, heart and metabolic disease	Disease models, Drug development, Gene expression, Neuro-stimulation, Optogenetics, Transgenic/knockout models, Basic research, Molecular and cellular biology, Translational research
Papsuev, Oleg MD/PhD	Clinician Investigator (NS)	Schizophrenia
Solmi, Marco MD, PhD, Psychiatrist	Clinician Investigator (NS)	Addiction, Anxiety, Attention deficit hyperactivity disorder (ADHD), Autism, Bipolar, Dementia, Depression, Mental health, Schizophrenia, Suicide	Clinical research, Clinical trials, Cluster randomized trials, Cohort studies, Epidemiology, Health research methods, Neuro-stimulation, Pharmacology, Pragmatic trials, Surveys, Systematic reviews
Tiberi, Mario PhD	Senior Scientist (NS)	Parkinson's, Schizophrenia, Stroke	Basic research, Drug development, Molecular and cellular biology, Proteomics, Translational research

Related Resources

Mental health research at The Ottawa Hospital

Search for clinical trials at The Ottawa Hospital related to this disease or condition.